Aquestive Therapeutics (AQST) Inventory Average (2018 - 2026)

Aquestive Therapeutics has reported Inventory Average for 9 years, with the latest figure at $7.7 million in Q2 2026.

• On a quarterly basis, Inventory Average rose 0.71% year-over-year to $7.7 million in Q2 2026; TTM through Jun 2026 was $7.7 million, a 0.71% increase from a year earlier, with the FY2025 full-year figure at $6.1 million, down 4.68% from the prior year.
• Inventory Average was $7.7 million for Q2 2026 at Aquestive Therapeutics, up from $7.1 million in the prior quarter.
• The five-year high for Inventory Average was $8.0 million in Q3 2025, with the low at $4.3 million in Q1 2022.
• Average Inventory Average over 5 years is $6.7 million, with a median of $6.8 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Inventory Average jumped 105.77% in 2022, then fell 8.69% in 2025.
• Over 5 years, Inventory Average stood at $6.3 million in 2022, then advanced by 10.74% to $6.9 million in 2023, then decreased by 5.65% to $6.5 million in 2024, then advanced by 7.56% to $7.0 million in 2025, then rose by 9.81% to $7.7 million in 2026.
• The last three Inventory Average figures came in at $7.7 million (Q2 2026), $7.1 million (Q1 2026), and $7.0 million (Q4 2025), per Business Quant data.